Distribution agreement in the UK regarding the Nitrous Oxide Detector

BeaconMedaes, part of the Atlas Copco Group, which already offers Medclair's central solutions for sustainable nitrous oxide management, has entered into a distribution agreement with Medclair regarding the personal detector for nitrous oxide exposure, in the UK. In addition to distribution, the agreement also covers service and support.

The agreement is expected to lead to better exposure and increased sales of products in the UK. Quote from BeaconMedaes:

"The exclusive distribution of Medclair AB:s Nitrous Oxide Detector is a monumental stride in our unwavering quest to equip the healthcare sector with solutions that are not only environmentally responsible but also paramount in ensuring clinical safety" says Paul Owen, UK- Sustainability Sales Manager at BeaconMedaes UK. "This partnership is a testament to our dedication to sustainability and our relentless pursuit of technological advancements that serve the healthcare industry and forms an integral part of the BeaconMedaes turnkey sustainability offering"

“BeaconMedaes is an important partner for us. In a short time they have positioned our central destruction facility as an established product in the UK and they are successfully driving several businesses forward”, says Jonas Lundh, CEO of Medclair AB. “The next logical step is that Beacon now chooses to include our NOD. This will greatly increase the product’s exposure in the UK, which is such an important market for us.”